Optic neuritis with visual field defect--possible Ibuprofen-related toxicity
- PMID: 16507621
- DOI: 10.1345/aph.1G451
Optic neuritis with visual field defect--possible Ibuprofen-related toxicity
Abstract
Objective: To report a case of optic neuritis with visual field defect associated with ibuprofen.
Case summary: A 41-year-old white man developed blurred vision in his right eye and pain with eye and head movements that lasted 2 days after use of ibuprofen 400 mg 3 times daily during the preceding 3 weeks. Medical and family histories were negative for significant related disease. Ophthalmologic examination revealed a marked decrease in visual acuity to 20/200 in the right eye with quadrant visual field loss and absent responses in visual evoked potential (VEP). After discontinuation of the drug and treatment with high-dose intravenous methylprednisolone and subcutaneous low-molecular-weight heparin, the patient's vision improved to 20/70, the visual field defect vanished, and the VEP returned to almost normal values during a 1 year follow-up period. An objective causality assessment revealed that the adverse reaction was possibly related to ibuprofen.
Discussion: Ocular toxicity with blurred vision and centrocecal visual field defects have been rarely associated with long-term ibuprofen intake. We report a case of retrobulbar optic neuritis with quadrant visual field defect following short-term but regular ibuprofen intake. Although idiopathic optic neuritis cannot be completely ruled out, the absence of other risk factors and additional findings plus the improvement after discontinuation of the drug speak for isolated toxic optic neuritis of the right eye.
Conclusions: Drug toxicity is an important differential diagnosis in retrobulbar optic neuritis. Clinicians should be aware of the potential optic toxicity, even with short-term use of a drug, and perform a thorough medication history in every patient with visual disturbances without a clear cause.
Similar articles
-
[High-dose intravenous immunoglobulins for treatment of optic neuritis in Guillain-Barré syndrome].Klin Monbl Augenheilkd. 2007 Dec;224(12):932-4. doi: 10.1055/s-2007-963674. Klin Monbl Augenheilkd. 2007. PMID: 18260057 German.
-
Optic neuritis with concurrent etanercept and isoniazid therapy.Ann Pharmacother. 2005 Dec;39(12):2131-5. doi: 10.1345/aph.1G279. Epub 2005 Nov 1. Ann Pharmacother. 2005. PMID: 16264061
-
[Recurrence of a retrobulbar neuritis? Classic VEP and missing periocular pain].Klin Monbl Augenheilkd. 2005 Jan;222(1):58-61. doi: 10.1055/s-2004-813828. Klin Monbl Augenheilkd. 2005. PMID: 15678403 German.
-
Visual field changes in methotrexate therapy. Case report and review of the literature.J Med Liban. 2006 Jul-Sep;54(3):164-7. J Med Liban. 2006. PMID: 17190135 Review.
-
[What is new in neuro-ophthalmology? Diagnosis, therapy and patient education in optic nerve neuritis].Klin Monbl Augenheilkd. 1993 Sep;203(3):159-66. doi: 10.1055/s-2008-1045662. Klin Monbl Augenheilkd. 1993. PMID: 8264205 Review. German.
Cited by
-
Systemic Medications and Their Ocular Side Effects.Cureus. 2024 Dec 2;16(12):e74976. doi: 10.7759/cureus.74976. eCollection 2024 Dec. Cureus. 2024. PMID: 39744265 Free PMC article. Review.
-
Drug-Induced Cognitive Impairment.Drug Saf. 2025 Apr;48(4):339-361. doi: 10.1007/s40264-024-01506-5. Epub 2024 Dec 24. Drug Saf. 2025. PMID: 39718691 Free PMC article. Review.
-
Transient tunnel vision and altered consciousness after a single dose of ibuprofen.J Int Med Res. 2022 Sep;50(9):3000605221126660. doi: 10.1177/03000605221126660. J Int Med Res. 2022. PMID: 36173005 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources